Canadian women’s health company Blair Health has raised CAD$4.24 million in pre-seed funding to expand a care model first developed to tackle long waits for menopause specialists into pelvic health, urology and weight management.
The Toronto-based company has built technology that translates specialist-designed assessments, treatment protocols and escalation pathways into software that can be used by family physicians and nurse practitioners, with specialists providing oversight for more complex cases.
The oversubscribed round, Blair’s first institutional financing, brings its total funding to CAD $4.5 million and will support expansion across Canada and the US. The round was co-led by BDC’s Thrive Venture Fund, Accelia Capital and Ogaei Investments, with participation from Ontario Centre of Innovation and angel investors.
“The fundamental problem in healthcare today is that the traditional model for delivering specialist care doesn’t scale,” said Madge Rumman, co-founder and CEO of Blair Health.
“We’ve spent the last year proving that specialist knowledge can be encoded into technology without removing the clinician from care, and that the same architecture can be applied across specialties.”
Addressing long waiting lists for specialist care
Blair began with menopause, where it says women in Canada can wait up to two years for a specialist appointment. Its menopause pathway was developed with co-founder and chief medical officer Dr Lindsay Shirreff, an obstetrician-gynaecologist and one of a small number of fellowship-trained menopause subspecialists practising in Canada.
Rather than replacing clinicians with a digital service, Blair’s model is designed to enable generalist providers to deliver care using specialist-developed clinical pathways. Its software incorporates assessment logic, guideline-informed treatment protocols, escalation triggers and follow-up pathways, while patients can track symptoms between appointments and message their provider.
Blair says its menopause pathway has achieved 98.7% clinical accuracy against its own clinical dataset, while a provider can be trained to deliver it in under four hours.
The company is now applying the same model beyond menopause. It has developed pathways in urology and pelvic health, led by urologist Dr Sarah Peltz, and clinical nutrition and weight management, led by gastroenterologist and obesity medicine physician Dr Pooja Singhal, all running on the same underlying technology.
More than 2,300 women have signed up since Blair launched direct-to-consumer in May 2025. It now operates across every Canadian province and six US states, with between 55% and 65% of steady-state visits involving follow-up care rather than one-off consultations.
Blair is also expanding through employers. Canadian pilots across professional services, hospitality and financial services have converted into recurring annual contracts, with the employer channel growing from close to zero to around half of the company’s revenue in the first half of 2026.
The funding will be used to accelerate engineering and product development, grow Blair’s clinical operations and provider network, expand its employer business in Canada and the US, and work with Canadian public-sector health systems.